Skip to content

FP7H2020HORIZON

Institut Pasteur de Lille Fondation

Country
FRFrance
Defence projects
0
Projects, all programmes
19
As coordinator
2
EU contribution (CORDIS)
EUR 8,466,900
Active
2008 to 2025

Projects

19 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
FACTORSBiological Factors in Fleas: Determinants of Physiology and Pathogen TransmissionHORIZON2025CoordinatorEUR 242,261
TBVAC-HORIZONImproving understanding of lung immunity in tuberculosis to establish a diverse, innovative TB vaccine pipeline targeting mucosal immunityHORIZON2023ParticipantEUR 491,000
FAIRFLAGELLIN AEROSOL THERAPY AS AN IMMUNOMODULATORY ADJUNCT TO THE ANTIBIOTIC TREATMENT OF DRUG-RESISTANT BACTERIAL PNEUMONIAH20202020Third partyNot stated
ERA4TBEUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSISH20202020ParticipantEUR 3,251,250
ImmunoBileBile acid, immune-metabolism, lipid and glucose homeostasisH20202016Third partyNot stated
PERISCOPEPERtussIS COrrelates of Protection Europe - Sofia ref.: 115910H20202016ParticipantEUR 799,998
CoSTREAMCommon mechanisms and pathways in Stroke and Alzheimer's disease.H20202015ParticipantEUR 324,875
TBVAC2020TBVAC2020; Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical developmentH20202015ParticipantEUR 538,464
RESOLVEA systems biology approach to RESOLVE the molecular pathology of two hallmarks of patients with metabolic syndrome and its co-morbidities; hypertriglyceridemia and low HDL-cholesterolFP72013ParticipantEUR 771,602
NANOREGA common European approach to the regulatory testing of nanomaterialsFP72013ParticipantEUR 17,504
AGEDBRAINSYSBIOSYSTEMS BIOLOGY OF PATHWAYS INVOLVING BRAIN AGEINGFP72013ParticipantEUR 300,000
BIOMARCAREBiomarker for Cardiovascular Risk Assessment in EuropeFP72011ParticipantEUR 53,945
HAIFREEA Novel Filtration Technology Targeted at Enhancing the European Healthcare System´s Efforts in Restraining the Spread of the Hospital InfectionFP72011ParticipantEUR 7,572
THESCHISTOVACThe targeted development of a new generation Vaccine for SchistosomiasisFP72010ParticipantEUR 363,030
NEWTBVACDiscovery and preclinical development of new generation tuberculosis vaccinesFP72010ParticipantEUR 379,500
TB PAN-NETPan-European network for the study and clinical management of drug resistant tuberculosisFP72009ParticipantEUR 211,989
P16 AND METABOLISMThe role of p16INK4a in the development of obesity and insulin resistanceFP72009CoordinatorEUR 164,311
TOBITargeting OBesity-driven InflammationFP72008ParticipantEUR 239,400
HOMITBHost and microbial molecular dissection of pathogenesis and immunity in tuberculosisFP72008ParticipantEUR 310,200

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.